Altan Ercan

1.1k total citations
19 papers, 877 citations indexed

About

Altan Ercan is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Altan Ercan has authored 19 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Immunology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Altan Ercan's work include Glycosylation and Glycoproteins Research (12 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Galectins and Cancer Biology (6 papers). Altan Ercan is often cited by papers focused on Glycosylation and Glycoproteins Research (12 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Galectins and Cancer Biology (6 papers). Altan Ercan collaborates with scholars based in United States, Ireland and United Kingdom. Altan Ercan's co-authors include Peter A. Nigrović, Pauline M. Rudd, Christopher M. West, Margaret E. Ackerman, Jing Cui, Galit Alter, Kevin D. Deane, Austin W. Boesch, Kavitha Baruah and Max Crispin and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Altan Ercan

19 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Altan Ercan United States 13 549 422 401 80 72 19 877
Susan C. Howard United States 16 592 1.1× 330 0.8× 201 0.5× 63 0.8× 131 1.8× 27 999
Mitchell E. Reff United States 21 781 1.4× 387 0.9× 555 1.4× 34 0.4× 36 0.5× 41 1.2k
Mara Hareuveni Israel 15 593 1.1× 564 1.3× 267 0.7× 23 0.3× 78 1.1× 25 1.1k
Rosina Plomp Netherlands 16 915 1.7× 626 1.5× 768 1.9× 16 0.2× 91 1.3× 20 1.3k
René G. Ott Austria 10 457 0.8× 367 0.9× 247 0.6× 163 2.0× 14 0.2× 15 931
Wim J.E. van Esch Netherlands 15 450 0.8× 605 1.4× 399 1.0× 23 0.3× 19 0.3× 26 995
Marco Cavallari Switzerland 16 378 0.7× 809 1.9× 252 0.6× 15 0.2× 101 1.4× 26 1.3k
Søren Mouritsen Denmark 17 345 0.6× 383 0.9× 212 0.5× 15 0.2× 121 1.7× 25 755
Marc Van Regenmortel France 8 797 1.5× 523 1.2× 704 1.8× 24 0.3× 43 0.6× 9 1.6k
Pascal Dalbon France 15 430 0.8× 160 0.4× 267 0.7× 40 0.5× 20 0.3× 26 998

Countries citing papers authored by Altan Ercan

Since Specialization
Citations

This map shows the geographic impact of Altan Ercan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Altan Ercan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Altan Ercan more than expected).

Fields of papers citing papers by Altan Ercan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Altan Ercan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Altan Ercan. The network helps show where Altan Ercan may publish in the future.

Co-authorship network of co-authors of Altan Ercan

This figure shows the co-authorship network connecting the top 25 collaborators of Altan Ercan. A scholar is included among the top collaborators of Altan Ercan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Altan Ercan. Altan Ercan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ercan, Altan. (2020). Sex effect on the correlation of immunoglobulin G glycosylation with rheumatoid arthritis disease activity. TURKISH JOURNAL OF BIOLOGY. 44(6). 406–416. 6 indexed citations
2.
Ercan, Altan, Wendy M. Kohrt, Jing Cui, et al.. (2017). Estrogens regulate glycosylation of IgG in women and men. JCI Insight. 2(4). 104 indexed citations
3.
Cheng, Hao, Henning Stöckmann, B Adamczyk, et al.. (2017). High-throughput characterization of the functional impact of IgG Fc glycan aberrancy in juvenile idiopathic arthritis. Glycobiology. 27(12). 1099–1108. 26 indexed citations
4.
Reinink, Peter, et al.. (2015). Expression Patterns of Bovine CD1 In Vivo and Assessment of the Specificities of the Anti-Bovine CD1 Antibodies. PLoS ONE. 10(3). e0121923–e0121923. 5 indexed citations
5.
Dauber, Andrew, Altan Ercan, Jack Y. Lee, et al.. (2014). Congenital disorder of fucosylation type 2c (LADII) presenting with short stature and developmental delay with minimal adhesion defect. Human Molecular Genetics. 23(11). 2880–2887. 29 indexed citations
6.
Ackerman, Margaret E., Max Crispin, Xiaojie Yu, et al.. (2013). Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. Journal of Clinical Investigation. 123(5). 2183–2192. 279 indexed citations
7.
Ercan, Altan, Michael Barnes, Melissa M. Hazen, et al.. (2012). Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation. Arthritis & Rheumatism. 64(9). 3025–3033. 27 indexed citations
8.
Ercan, Altan, Jing Cui, Melissa M. Hazen, et al.. (2012). Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis. Arthritis Research & Therapy. 14(2). R43–R43. 23 indexed citations
9.
Adamczyk, B, Weston B. Struwe, Altan Ercan, Peter A. Nigrović, & Pauline M. Rudd. (2012). Characterization of Fibrinogen Glycosylation and Its Importance for Serum/Plasma N-Glycome Analysis. Journal of Proteome Research. 12(1). 444–454. 53 indexed citations
10.
Ercan, Altan, Jing Cui, Dereck E. W. Chatterton, et al.. (2010). Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis & Rheumatism. 62(8). 2239–2248. 181 indexed citations
11.
Ercan, Altan, William M. Tay, Steven H. Grossman, & Li‐June Ming. (2009). Mechanistic role of each metal ion in Streptomyces dinuclear aminopeptidase: Peptide hydrolysis and 7×1010-fold rate enhancement of phosphodiester hydrolysis. Journal of Inorganic Biochemistry. 104(1). 19–29. 7 indexed citations
12.
Ercan, Altan, Maria Panico, Mark Sutton‐Smith, et al.. (2006). Molecular Characterization of a Novel UDP-galactose:Fucoside α3-Galactosyltransferase That Modifies Skp1 in the Cytoplasm of Dictyostelium. Journal of Biological Chemistry. 281(18). 12713–12721. 18 indexed citations
13.
14.
Wel, Hanke van der, Altan Ercan, & Christopher M. West. (2005). The Skp1 Prolyl Hydroxylase from Dictyostelium Is Related to the Hypoxia-inducible Factor-α Class of Animal Prolyl 4-Hydroxylases. Journal of Biological Chemistry. 280(15). 14645–14655. 43 indexed citations
15.
Ketcham, Catherine M., Fei Wang, S. Zoë Fisher, et al.. (2004). Specificity of a Soluble UDP-Galactose:Fucoside α1,3-Galactosyltransferase That Modifies the Cytoplasmic Glycoprotein Skp1 in Dictyostelium. Journal of Biological Chemistry. 279(28). 29050–29059. 21 indexed citations
16.
Ercan, Altan & Christopher M. West. (2004). Kinetic analysis of a Golgi UDP-GlcNAc:polypeptide-Thr/Ser N-acetyl-α-glucosaminyltransferase from Dictyostelium. Glycobiology. 15(5). 489–500. 6 indexed citations
17.
Ercan, Altan & Steven H. Grossman. (2003). Proteolytic susceptibility of creatine kinase isozymes and arginine kinase. Biochemical and Biophysical Research Communications. 306(4). 1014–1018. 6 indexed citations
18.
Ercan, Altan, et al.. (2003). Iron(III)–Chelex resin complex as a prototypical heterogeneous catalyst for phosphodiester hydrolysis. Catalysis Communications. 4(10). 549–553. 18 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan C. Howard Breakdown of academic impact, for papers by Mitchell E. Reff Breakdown of academic impact, for papers by Mara Hareuveni Breakdown of academic impact, for papers by Rosina Plomp Breakdown of academic impact, for papers by René G. Ott Breakdown of academic impact, for papers by Wim J.E. van Esch Breakdown of academic impact, for papers by Marco Cavallari Breakdown of academic impact, for papers by Søren Mouritsen Breakdown of academic impact, for papers by Marc Van Regenmortel Breakdown of academic impact, for papers by Pascal Dalbon
Rankless by CCL
2026